Thermo Fisher Scientific acquired Sanofi's factory on September 3, 2025.
5 reports, 5 independent
Updated Sep 3
Gone quiet
Reached 5 outlets in its first 24 hours
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Thermo Fisher Scientific acquired Sanofi's factory on September 3, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Thermo Fisher acquired Sanofi's factory.1 source
Thermo Fisher continues manufacturing Sanofi therapies at the acquired Ridgefield site.1 source
Keep exploring
Part of
Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.Also in this story
- Skyclarys announced its international expansion into Brazil and the U.K. on July 22, 2025.
- Organon acquired U.S. rights to TOFIDENCE from Biogen and laid off employees at its Jersey City headquarters.
- Biogen enhances patient outcomes through key drugs and therapies, while NIH studies reveal global incidence of ALS and CDC projects rising patient numbers in the U.S.
- Sooin was appointed Chief Business and Strategy Officer at Galapagos, which also announced a partnership with Gilead.
The entities involved
-
Sanofi
company in Milan, Italy
Nothing else this week.
-
Thermo Fisher Scientific (Netherlands)
Nothing else this week.
Coverage
Newest first; wire copies grouped- Motley FoolWhy Thermo Fisher Scientific Stock Tumbled Today The medical device specialist announced the closing of not one, but two acquisitions. One was a $4 billion purchase of a healthcare business, the othe
- Business WireThermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site Expanded Strategic Partnership Enables Additional U.S. Manufacturing Capacity to Serve Increased Demand for Phar
- Insider MonkeyThermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best long term low volatility stocks to buy now. On July 16
- Pharmaceutical TechnologyThermo Fisher acquires Sanofi’s steriles manufacturing site in US Thermo Fisher Scientific has signed an agreement for the acquisition of Sanofi’s steriles manufacturing site located in Ridgefield in
- ReutersThermo Fisher acquires Sanofi's New Jersey manufacturing site (Reuters) -Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce critical medicin